BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20924032)

  • 1. Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical study.
    Langer R; Mutze K; Becker K; Feith M; Ott K; Höfler H; Keller G
    J Clin Pathol; 2010 Nov; 63(11):994-8. PubMed ID: 20924032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer.
    Mutze K; Langer R; Becker K; Ott K; Novotny A; Luber B; Hapfelmeier A; Göttlicher M; Höfler H; Keller G
    Ann Surg Oncol; 2010 Dec; 17(12):3336-43. PubMed ID: 20585871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas.
    Campos B; Bermejo JL; Han L; Felsberg J; Ahmadi R; Grabe N; Reifenberger G; Unterberg A; Herold-Mende C
    Cancer Sci; 2011 Feb; 102(2):387-92. PubMed ID: 21143702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of p53 mutations in oesophageal adenocarcinoma: final results of a 15-year prospective study.
    Madani K; Zhao R; Lim HJ; Casson AG
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1427-32. PubMed ID: 20227286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
    Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas.
    Ishihama K; Yamakawa M; Semba S; Takeda H; Kawata S; Kimura S; Kimura W
    J Clin Pathol; 2007 Nov; 60(11):1205-10. PubMed ID: 17720775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus.
    Evangelou K; Kotsinas A; Mariolis-Sapsakos T; Giannopoulos A; Tsantoulis PK; Constantinides C; Troupis TG; Salmas M; Kyroudis A; Kittas C; Gorgoulis VG
    J Clin Pathol; 2008 May; 61(5):601-5. PubMed ID: 17908803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
    Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
    Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated immunoreactivity against class I histone deacetylases in adenomyosis.
    Liu X; Nie J; Guo SW
    Gynecol Obstet Invest; 2012; 74(1):50-5. PubMed ID: 22539030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of histone deacetylase 2 is found in human gastric cancer.
    Song J; Noh JH; Lee JH; Eun JW; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Nam SW
    APMIS; 2005 Apr; 113(4):264-8. PubMed ID: 15865607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High pretherapeutic thymidylate synthetase and MRP-1 protein levels are associated with nonresponse to neoadjuvant chemotherapy in oesophageal adenocarcinoma patients.
    Langer R; Ott K; Feith M; Lordick F; Specht K; Becker K; Hofler H
    J Surg Oncol; 2010 Oct; 102(5):503-8. PubMed ID: 20589706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung.
    Minamiya Y; Ono T; Saito H; Takahashi N; Ito M; Mitsui M; Motoyama S; Ogawa J
    Lung Cancer; 2011 Nov; 74(2):300-4. PubMed ID: 21466904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma.
    Rikimaru T; Taketomi A; Yamashita Y; Shirabe K; Hamatsu T; Shimada M; Maehara Y
    Oncology; 2007; 72(1-2):69-74. PubMed ID: 18004079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival.
    Tickenbrock L; Klein HU; Trento C; Hascher A; Göllner S; Bäumer N; Kuss R; Agrawal S; Bug G; Serve H; Thiede C; Ehninger G; Stadt UZ; McClelland M; Wang Y; Becker A; Koschmieder S; Berdel WE; Dugas M; Müller-Tidow C;
    Leuk Res; 2011 May; 35(5):620-5. PubMed ID: 21176959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expressions of HDAC1 and HDAC2 in prostate cancer and their clinical implications].
    Yin CK; Fu Q
    Zhonghua Nan Ke Xue; 2013 Aug; 19(8):699-703. PubMed ID: 24010203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.
    Rizk NP; Venkatraman E; Bains MS; Park B; Flores R; Tang L; Ilson DH; Minsky BD; Rusch VW;
    J Clin Oncol; 2007 Feb; 25(5):507-12. PubMed ID: 17290058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of postchemoradiation endoscopic brush cytology and biopsy in predicting residual esophageal adenocarcinoma.
    Peng HQ; Halsey K; Sun CC; Manucha V; Nugent S; Rodgers WH; Suntharalingam M; Greenwald BD
    Cancer; 2009 Dec; 117(6):463-72. PubMed ID: 19806643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative and positive regulation of gene expression by mouse histone deacetylase 1.
    Zupkovitz G; Tischler J; Posch M; Sadzak I; Ramsauer K; Egger G; Grausenburger R; Schweifer N; Chiocca S; Decker T; Seiser C
    Mol Cell Biol; 2006 Nov; 26(21):7913-28. PubMed ID: 16940178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Resetkova E; Wang H; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Hamilton SR; Albarracin CT
    Clin Cancer Res; 2006 Aug; 12(15):4598-604. PubMed ID: 16899607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.